Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum protein-expression profiling using the ProteinChip biomarker system.

Kate Gilbert1, Sharel Figueredo, Xiao-Ying Meng

  • 1Ciphergen Biosystems, Inc, Fremont, CA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|March 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early cancer detection in a large American Cancer Society cohort study: Retrospective analysis of methylated DNA biomarkers.

Cancer·2026
Same author

Preclinical circulating tumor DNA shedding duration and prognostic implications of modeling 3669 patients with cancer in the American Cancer Society Cancer Prevention Study-3 and Circulating Cell-Free Genome Atlas Substudy 3.

Cancer·2026
Same author

Targeting AKT via SC79 for Photoreceptor Preservation in Retinitis Pigmentosa Mouse Models.

Biomedicines·2026
Same author

Multicancer Early Detection Blood Test Performance in Cancer Survivors From the PATHFINDER Study.

JCO precision oncology·2025
Same author

Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study.

The Lancet. Oncology·2025
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Serum proteomic profiling aids disease biomarker discovery. Combining chromatography techniques and robotics simplifies complex serum samples, enabling the identification of clinically relevant protein biomarkers.

Area of Science:

  • Biochemistry
  • Proteomics
  • Biotechnology

Background:

  • Serum protein-expression profiling is crucial for identifying disease biomarkers.
  • The dynamic range of serum proteomes necessitates complex sample preparation.
  • Existing methods require enhancement for comprehensive proteomic analysis.

Purpose of the Study:

  • To develop an advanced method for serum proteomic profiling.
  • To improve the representation of the serum proteome in biomarker discovery.
  • To enhance the efficiency and throughput of sample processing.

Main Methods:

  • Utilized a combination of conventional column chromatography and array-based chromatography for serum fractionation.
  • Employed robotics for high-throughput sample processing.

Related Experiment Videos

  • Implemented rigorous data preprocessing and postprocessing steps for analysis.

    • Main Results:

    • Successfully simplified the complex serum proteome into manageable subproteomes.
    • Achieved greater representation of the serum proteome through advanced fractionation.
    • Generated substantial data amenable to robust statistical analysis.

    Conclusions:

    • The developed methodology enhances the discovery of statistically sound and clinically meaningful protein biomarkers.
    • This approach offers a more comprehensive view of the serum proteome.
    • Optimized serum profiling is key to advancing diagnostic and therapeutic marker identification.